Region:Middle East
Author(s):Geetanshi
Product Code:KRAA6071
Pages:84
Published On:January 2026

By Type:The market can be segmented into various types of diagnostic devices and kits. The subsegments include Blood Glucose Monitoring Devices, Infectious Disease Testing Kits, Cardiac Markers Testing Devices, Coagulation Testing Devices, Pregnancy and Fertility Testing Kits, and Others. Each of these subsegments plays a crucial role in addressing specific healthcare needs.

By End-User:The end-user segmentation includes Hospitals, Clinics, Home Care Settings, Emergency Medical Services, and Others. Each of these segments utilizes POC diagnostics differently, catering to the specific needs of their patient populations.

The Oman Point of Care POC Diagnostics Market is characterized by a dynamic mix of regional and international players. Leading participants such as Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Cepheid, Quidel Corporation, BD (Becton, Dickinson and Company), Bio-Rad Laboratories, Hologic, Inc., Thermo Fisher Scientific, Medtronic, Ortho Clinical Diagnostics, Alere Inc., Luminex Corporation, GenMark Diagnostics, Mylab Discovery Solutions contribute to innovation, geographic expansion, and service delivery in this space.
The future of the POC diagnostics market in Oman appears promising, driven by ongoing technological advancements and increasing healthcare investments. The government is expected to enhance healthcare infrastructure, facilitating greater access to POC testing. Additionally, the integration of artificial intelligence in diagnostics is anticipated to streamline processes and improve accuracy. As healthcare providers become more aware of the benefits of POC diagnostics, adoption rates are likely to rise, fostering a more efficient healthcare system.
| Segment | Sub-Segments |
|---|---|
| By Type | Blood Glucose Monitoring Devices Infectious Disease Testing Kits Cardiac Markers Testing Devices Coagulation Testing Devices Pregnancy and Fertility Testing Kits Others |
| By End-User | Hospitals Clinics Home Care Settings Emergency Medical Services Others |
| By Application | Disease Diagnosis Health Monitoring Screening Programs Others |
| By Distribution Channel | Direct Sales Online Sales Distributors Retail Pharmacies Others |
| By Technology | Lateral Flow Assays Microfluidics Molecular Diagnostics Others |
| By Region | Muscat Dhofar Al Batinah Al Dakhiliyah Others |
| By Policy Support | Government Subsidies Tax Incentives Grants for Research and Development Others |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Hospital Laboratories | 65 | Lab Managers, Medical Technologists |
| Primary Care Clinics | 52 | General Practitioners, Clinic Administrators |
| Pharmacies Offering POC Testing | 38 | Pharmacists, Pharmacy Managers |
| Public Health Organizations | 28 | Public Health Officials, Epidemiologists |
| Diagnostic Device Distributors | 42 | Sales Representatives, Distribution Managers |
The Oman Point of Care POC Diagnostics Market is valued at approximately USD 140 million, reflecting a significant growth trend driven by the increasing prevalence of chronic diseases and advancements in diagnostic technology.